- Home
- FPH vs INBX Comparison
FPH vs INBX Comparison
Compare FPH & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPH
- INBX
- Stock Information
- Founded
- FPH 2009
- INBX 2010
- Country
- FPH United States
- INBX United States
- Employees
- FPH N/A
- INBX N/A
- Industry
- FPH Real Estate
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- FPH Finance
- INBX Health Care
- Exchange
- FPH Nasdaq
- INBX Nasdaq
- Market Cap
- FPH 267.1M
- INBX 218.9M
- IPO Year
- FPH 2017
- INBX 2020
- Fundamental
- Price
- FPH $3.55
- INBX $13.92
- Analyst Decision
- FPH
- INBX Hold
- Analyst Count
- FPH 0
- INBX 1
- Target Price
- FPH N/A
- INBX N/A
- AVG Volume (30 Days)
- FPH 195.3K
- INBX 81.4K
- Earning Date
- FPH 01-16-2025
- INBX 11-14-2024
- Dividend Yield
- FPH N/A
- INBX N/A
- EPS Growth
- FPH 35.57
- INBX N/A
- EPS
- FPH 0.70
- INBX 119.38
- Revenue
- FPH $196,899,000.00
- INBX $1,568,000.00
- Revenue This Year
- FPH N/A
- INBX N/A
- Revenue Next Year
- FPH N/A
- INBX N/A
- P/E Ratio
- FPH $5.10
- INBX $0.12
- Revenue Growth
- FPH 79.04
- INBX 19.24
- 52 Week Low
- FPH $2.60
- INBX $10.80
- 52 Week High
- FPH $4.39
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- FPH 34.56
- INBX 38.33
- Support Level
- FPH $3.42
- INBX $14.53
- Resistance Level
- FPH $3.85
- INBX $15.24
- Average True Range (ATR)
- FPH 0.13
- INBX 0.72
- MACD
- FPH -0.05
- INBX -0.10
- Stochastic Oscillator
- FPH 18.18
- INBX 19.16
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Commercial. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.